Third Point LLC is an SEC-registered investment adviser based in New York City. The firm was
founded in 1995 by Daniel S. Loeb, who serves as CEO and oversees all investment activity.
Daniel Loeb has more than 27 years of experience in the financial markets, with particular
emphasis on special situation equities, distressed debt and risk arbitrage. Third Point employs an event-driven, value-oriented investment style. The Firm seeks to identify situations where we anticipate a catalyst will unlock value. Third Point LLC’s team includes professionals focused on investment activity, risk management, and trading. This team is supported by highly experienced accounting, operations, investor relations and marketing, and legal and compliance professionals. For more information, visit www.thirdpointventures.com.
New Science Ventures, LLC (NSV) is a New York-based venture capital firm that invests in companies using novel scientific approaches in the Life Sciences sector (biotech, pharma and medical devices) and the Information Technology sector (semiconductors, photonics and advanced materials). NSV was founded in 2004 by Somu Subramaniam, Managing Partner, and Tom Lavin, Partner, and has invested approximately $300 million in both early and late stage companies located in the US, Europe and India. For more information, visit www.newscienceventures.com.
640 Lee Road, Ste 118,
Wayne, PA 19087
P: 267.465.7565
Email: dpfeiffer@ralexar.com
Legal and Copyright Disclaimer | Privacy Policy
© 2021 Ralexar Therapeutics.
All Rights Reserved.
Web Design & Development time4design - Bucks County Web Design.